Investigation on phosphate dependent glutaminase (EC 3.5.1.2) activity in host tissues of EAC-bearing mice and response of liver EC 3.5.1.2 on Cu-ATP therapy.
Phosphate-dependent glutaminase activity in spleen, kidney, brain and liver is increased after tumor cell inoculation and this activity gradually increases with the progression of the tumor. The increase in enzyme activity in the liver is significant. Studies of the response of liver glutaminase after Cu-ATP treatment reveals that Cu-ATP is capable of reducing the high glutaminase level in subjects with malignant tumors to the normal level.
Pal
S
S
Department of Cell Biology, Chittaranjan National Cancer Institute, Calcutta, India.
Nayak
K K
KK
Maity
P
P
D000255:Adenosine Triphosphate / Q000627:therapeutic use*; D000818:Animals; D001921:Brain / Q000201:enzymology; D002286:Carcinoma, Ehrlich Tumor / Q000188:drug therapy / Q000201:enzymology* / Q000473:pathology; D002455:Cell Division / Q000187:drug effects; D005972:Glutaminase / Q000032:analysis* / Q000037:antagonists & inhibitors; D007668:Kidney / Q000201:enzymology; D008099:Liver / Q000187:drug effects / Q000201:enzymology*; D051379:Mice; D013154:Spleen / Q000201:enzymology
C033874:copper adenosine triphosphate; D000255:Adenosine Triphosphate; D005972:Glutaminase